Ultragenyx Pharmaceutical
RARE
34,02 €
Share price
-2.70%
Change (1 day)
-21.78%
Change (1 year)
Categories
Ultragenyx Pharmaceutical (RARE) - Net assets
Net assets on the balance sheet as of December 2024 : €0.24 Billion
According to Ultragenyx Pharmaceutical's latest financial reports the company has €0.24 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Ultragenyx Pharmaceutical - Net assets on balance sheet (from 2012 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $€0.25 B | 1.17% |
| 2023-12-31 | $€0.24 B | -24.18% |
| 2022-12-31 | $€0.32 B | -59.66% |
| 2021-12-31 | $€0.81 B | -13.2% |
| 2020-12-31 | $€0.93 B | 60.82% |
| 2019-12-31 | $€0.58 B | 9.64% |
| 2018-12-31 | $€0.53 B | 66.55% |
| 2017-12-31 | $€0.31 B | -29.08% |
| 2016-12-31 | $€0.45 B | -7.23% |
| 2015-12-31 | $€0.48 B | 219.41% |
| 2014-12-31 | $€0.15 B | 319.1% |
| 2013-12-31 | $€36.28 M | -43.09% |
| 2012-12-31 | $€63.76 M | 678% |
| 2011-12-31 | $€8.19 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | €5.23 B | 2,057.09% | 🇺🇸 USA |
 | €0.17 B | -26.02% | 🇺🇸 USA |
 | -€0.36 Billion | -248.20% | 🇺🇸 USA |
 | €0.13 B | -44.36% | 🇺🇸 USA |